Membrane complement regulatory proteins
- PMID: 16338172
- DOI: 10.1016/j.clim.2005.10.014
Membrane complement regulatory proteins
Abstract
A number of proteins anchored on the cell surface function to protect host tissues from bystander injury when complement is activated. In humans, they include decay-accelerating factor (DAF, CD55), membrane cofactor protein (MCP, CD46), complement receptor 1 (CR1, CD35) and CD59. Although disease conditions directly attributable to abnormal function of these proteins are relatively rare, it has become evident from recent studies using animal models that membrane complement regulatory proteins are important modulators of tissue injury in many autoimmune and inflammatory disease settings. Evidence is also emerging to support a role of these proteins in regulating cellular immunity. In this article, we highlight recent advances on the in vivo biology of membrane complement regulatory proteins and discuss their relevance in human disease pathogenesis and therapeutics.
Similar articles
-
Complement regulatory proteins and autoimmunity.Arch Immunol Ther Exp (Warsz). 2000;48(5):367-72. Arch Immunol Ther Exp (Warsz). 2000. PMID: 11140463 Review.
-
Immunization against tumor cell surface complement-regulatory proteins.Curr Opin Investig Drugs. 2001 Jul;2(7):959-66. Curr Opin Investig Drugs. 2001. PMID: 11757799 Review.
-
Complement regulatory proteins are expressed at low levels in embryonic human, wild type and transgenic porcine neural tissue.Xenotransplantation. 2004 Jan;11(1):60-71. doi: 10.1111/j.1399-3089.2004.00084.x. Xenotransplantation. 2004. PMID: 14962294
-
Structure and function of decay accelerating factor CD55.J Lab Clin Med. 1994 Apr;123(4):485-91. J Lab Clin Med. 1994. PMID: 7511675 Review.
-
Expression and distribution of cell-membrane complement regulatory glycoproteins along the human respiratory tract.Am J Respir Crit Care Med. 1995 Sep;152(3):1087-93. doi: 10.1164/ajrccm.152.3.7545058. Am J Respir Crit Care Med. 1995. PMID: 7545058
Cited by
-
Complement in Tumourigenesis and the Response to Cancer Therapy.Cancers (Basel). 2021 Mar 10;13(6):1209. doi: 10.3390/cancers13061209. Cancers (Basel). 2021. PMID: 33802004 Free PMC article. Review.
-
Regulation of complement-dependent cytotoxicity by TGF-β-induced epithelial-mesenchymal transition.Oncogene. 2016 Apr 14;35(15):1888-98. doi: 10.1038/onc.2015.258. Epub 2015 Jul 6. Oncogene. 2016. PMID: 26148233 Free PMC article.
-
Examining the Role of Complement in Predicting, Preventing, and Treating Hemolytic Transfusion Reactions.Transfus Med Rev. 2019 Oct;33(4):217-224. doi: 10.1016/j.tmrv.2019.09.006. Epub 2019 Oct 18. Transfus Med Rev. 2019. PMID: 31679762 Free PMC article. Review.
-
CD55-deficiency in Jews of Bukharan descent is caused by the Cromer blood type Dr(a-) variant.Hum Genet. 2023 May;142(5):683-690. doi: 10.1007/s00439-021-02428-3. Epub 2022 Mar 21. Hum Genet. 2023. PMID: 35314883 Free PMC article.
-
Increased morbidity and mortality in murine cytomegalovirus-infected mice following allogeneic bone marrow transplant is associated with reduced surface decay accelerating factor expression.Clin Exp Immunol. 2010 Nov;162(2):379-91. doi: 10.1111/j.1365-2249.2010.04241.x. Epub 2010 Sep 14. Clin Exp Immunol. 2010. PMID: 20840652 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous